Kinoxis Therapeutics
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
Based based in Asia-Pacific (APAC), Australasia, Kinoxis Therapeutics works in biotechnology, therapeutics, founded in 2017.
Within the biotechnology, therapeutics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Asia-Pacific (APAC), Australasia.
The company is listed at the Series_B stage of development.
Its team size is recorded as c_00001_00010 employees.
Total disclosed funding stands at about $22.3M.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | Asia-Pacific (APAC), Australasia |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $22,259,646 |
Website: www.kinoxistherapeutics.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account